VIRAL KNOWLEDGE: The “genioux facts” knowledge news
Though preliminary, the early results for the two vaccines suggest researchers can develop effective Covid-19 shots, which would be a big help in taming the pandemic.
- Moderna Inc. MRNA 1.80% said its experimental coronavirus vaccine was 94.5% effective at protecting people from Covid-19.
- Researchers won’t have a full set of effectiveness data until a total of 151 people in the trial develop Covid-19 symptoms. Moderna expects that by the time it applies for government authorization.
- Pfizer Inc. and BioNTech SE said their experimental Covid-19 vaccine was more than 90% effective.
- Until proven vaccines are deployed at scale, the fight against coronavirus is one without an easily-defined weapon. While some countries are faring better than others, and some approaches have been a clear failure, no COVID-stricken nation can be sure of the right way forward.
Genioux knowledge fact condensed as an image.
- WSJ. Moderna Inc. MRNA 1.80% said its experimental coronavirus vaccine was 94.5% effective at protecting people from Covid-19 in an early look at pivotal study results, the second vaccine to hit a key milestone.
- The findings move the vaccine closer to wide use, because they indicate it is effective at preventing disease that causes symptoms, including severe cases.
- Moderna said it plans to ask federal health authorities by early December to clear the vaccine.
- How Messenger RNA Vaccines Work. The vaccine from Pfizer and BioNTech uses a new gene-based technology known as mRNA.
- Vaccines in the Works. Instead of using the whole virus to generate an immune response, these vaccines rely on coronavirus's outer spike proteins, which are what antibodies use to recognize the virus.
- When injected into a patient, the RNA enters healthy cells where it helps orchestrate the production of coronavirus spike proteins.
- “These are very impressive and very encouraging and exciting results,” Dr. Fauci said.
- U.S. stock futures rose on positive study results from another potential Covid-19 vaccine, with the S&P 500 set to open higher after ending last week at a record level.
- What was once a health crisis that Americans feared has evolved into one virtually everyone has experienced up close. That will affect behavior, but in many different ways.
- Biotechnology firm Moderna announced Monday that a preliminary analysis shows its experimental coronavirus vaccine is nearly 95 percent effective at preventing illness, including severe cases.
- While some countries are faring better than others, and some approaches have been a clear failure, no COVID-stricken nation can be sure of the right way forward.
- As explained in this worthwhile Wall Street Journal piece from yesterday, no-one even knows where most infections are taking place.
- Speaking with Jake Tapper on Sunday morning’s “State of the Union,” Fauci speculated that it may not be until the second or third quarter of 2021 that Americans might expect to “start approaching a degree of normality.”
Category 4: Coronavirus and other viruses
[genioux fact extracted from WSJ, NYT, WaPo, Fortune CEO Daily, CNN, The New York Post, Fox News]
Authors of genioux fact
Moderna’s Covid-19 Vaccine Is 94.5% Effective, Early Results Show, Peter Loftus, Nov. 16, 2020, WSJ, The Wall Street Journal.
U.S. Stocks Open Higher on Positive Moderna Vaccine Results, Mischa Frankl-Duval and Frances Yoon, Nov. 16, 2020, WSJ, The Wall Street Journal.
With 11 Million Cases in the U.S., the Coronavirus Has Gotten Personal for Most People, Amy Harmon, Lucy Tompkins, Audra D. S. Burch and Serge F. Kovaleski, Nov. 15, 2020, NYT, The New York Times.
Moderna’s coronavirus vaccine found to be nearly 95 percent effective in a preliminary analysis, Carolyn Y. Johnson, November 16, 2020, WaPo, The Washington Post.
CEODAILY, David Mayer, November 16, 2020, Fortune CEO Daily.
Social distancing, masks still necessary after getting COVID-19 vaccine: Fauci, Jackie Salo, November 15, 2020, the New York Post, CNN.